Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: Jan 28, 2021
Date Accepted: Jun 21, 2021
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Chest patch for continuous vital-sign monitoring: A clinical validation study during movement and controlled hypoxia.
ABSTRACT
Background:
Early warning scores in general wards are commonly limited by intermittent manual measurements; these are recognised as being time consuming and for impacting monitoring frequency. Wearable devices may support healthcare staff, improve patient safety and promote early deterioration detection. However available ambulatory monitoring devices need to be tested and validated before clinical implementation.
Objective:
The objective of this study is to determine the agreement between a chest-worn patch (VitalPatch®) and gold standard reference device for heart rate (HR) and respiratory rate (RR) measurements during movement and during gradual de-saturation in a controlled environment.
Methods:
After both VitalPatch and gold standard device (Philips MX450) were placed, participants performed 7 different movements: At rest, Sit-to-Stand, Tapping, Rubbing, Drinking, Turning Pages, and Using a Tablet. In a controlled environment. Participants were then made hypoxic gradually down to 80% peripheral oxygen saturations. The primary outcome measures were the accuracy, defined as the mean absolute error (MAE) of the VitalPatch estimates when compared with their gold-standards. We defined these to be clinical acceptable if within 5 beats per minute (bpm) for HR and 3 respirations per minute (rpm) for RR.
Results:
We acquired complete datasets of 29 participants. In the movement phase, HR estimates were within the pre-specified limits for all movements. For RR, estimates were also inside the acceptable range, with the exception of the Sit-to-Stand and Turning Pages movements, showing a MAE (95% CI) of 3.05 (2.48, 3.58) rpm and 3.45 (2.71, 4.11) rpm, respectively. For the hypoxia phase, these were always within the limits with an overall MAE for HR and RR of 0.72 (0.66, 0.78) bpm and 1.89 (1.75, 2.03) rpm, respectively. There were no significant differences in the VitalPatch performance across a range of oxygen desaturations.
Conclusions:
The VitalPatch was highly accurate throughout movement tests except for its RR estimation during two movements. This device was reliable throughout the hypoxia stages, with no significant accuracy differences in normoxia (≥ 90%), mild (89.9 - 85%) and severe hypoxia (< 85%). Clinical Trial: ISRCTN61535692
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.